AARTI DRUGS
Back to All Ratios
|
AARTI DRUGS Last 5 Year EV/CE History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EV/CE(x) | 2.46 | 2.07 | 2.85 | 3.86 | 1.50 |
What is the latest EV/CE ratio of AARTI DRUGS ?
Year | EV/CE |
---|---|
Mar2024 | 2.46 |
Mar2023 | 2.07 |
Mar2022 | 2.85 |
Mar2021 | 3.86 |
Mar2020 | 1.50 |
How is EV/CE of AARTI DRUGS Trending?
Years | EV/CE | % Change | |
---|---|---|---|
Mar2024 | 2.46 | 18.84 | |
Mar2023 | 2.07 | -27.37 | |
Mar2022 | 2.85 | -26.17 | |
Mar2021 | 3.86 | 157.33 | |
Mar2020 | 1.5 | - |
Other Financial Ratios of AARTI DRUGS
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/CE ratio of peers of AARTI DRUGS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AARTI DRUGS | ₹4,770.0 Cr | -2.9% | 11.3% | 7.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,273.0 Cr | 2.5% | 4.1% | -0.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹176,604.0 Cr | 0.5% | -2.9% | 35.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹126,316.0 Cr | 6.2% | 9.3% | 17.9% | Stock Analytics | |
CIPLA | ₹125,993.0 Cr | 4.9% | 2.9% | 1.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,795.0 Cr | 2.1% | 1.2% | -5% | Stock Analytics |
AARTI DRUGS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AARTI DRUGS | -2.9% |
11.3% |
7.1% |
SENSEX | -1.5% |
-2.5% |
0.2% |
You may also like the below Video Courses